Aevitas North is heading to Athens to present a capstone program for the Harvard Medical School Global Healthcare Leaders Program.

Aevitas North is an independent life sciences advisory practice founded by Charlotte Nortvedt, bringing over 25 years of international Medical Affairs leadership in neuroscience and rare diseases. The name reflects our purpose. Aevitas is from the Latin for lifecycle, because every medicine has a journey, and the decisions made at each stage shape whether it reaches the patients who need it. North is because good advisory work is about direction, clarity, and a fixed point of reference when things get complex. Working with biotech and biopharma companies, from ambitious startups to established international organisations, on Medical Affairs strategy, launch excellence, evidence generation, portfolio decisions, and board level scientific advisory. Aevitas North also offers career coaching for women in pharma and biotech, drawing on decades of leadership experience to support confidence, visibility, and growth at every career stage. Our focus spans rare genetic and childhood onset diseases and syndromes, neuroscience, and the broader life sciences ecosystem, always guided by one question: which patients need this most, and how does it reach them? Visit aevitasnorth.ch to learn more.